Good Morning, It’s Tuesday December 20th, 2011, I’m Christina Collins with CRWENewswire Stocks In Action

Marshall Edwards Incorporated - symbol MSHL - reported that the U.S. Patent and Trademark Office has issued a new patent, covering a number of the Company’s isoflavone-based compounds, including lead oncology drug candidates ME-143 and ME-344, and their pharmaceutical compositions

According to a sales agreement between the companies, TransCanada Corporation will acquire from a subsidiary of Canadian Solar Incorporated - symbol CSIQ - a 86 megawatts AC solar project portfolio for approximately $470 million Canadian dollars.

and lastly;

Salix Pharmaceuticals Limited - symbol SLXP - and Progenics Pharmaceuticals Incorporated - symbol PGNX - reported the successful outcome of the Phase 3 trial to evaluate the efficacy and safety of oral methylnaltrexone for the treatment of opioid-induced constipation in subjects with chronic, non-cancer pain.

Thank you for joining me and have a great day! For CRWE Newswire, Stocks In Action, I’m Christina Collins

*********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. crwenewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer (Read more at http://www.crwenewswire.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold crwenewswire.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.